Company news

Tetratherix Limited news in 2026

Tetratherix Limited's news releases, calls and decks from 2026, newest first.

View company

Application for quotation of securities - TTX

November 3, 2026

Application for quotation of securities - TTX

November 3, 2026

Details of Auditor Appointment/Resignation

October 29, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 29, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 29, 2026

TegenEOS Biologic Pathway

October 28, 2026

Notification of cessation of securities - TTX

October 21, 2026

Application for quotation of securities - TTX

October 21, 2026

Notice of Annual General Meeting/Proxy Form

October 11, 2026

Application for quotation of securities - TTX

October 7, 2026

Tegenix FDA Review Progress

October 5, 2026

Notification regarding unquoted securities - TTX

October 1, 2026

Line of sight ophthalmic tissue spacing US revenue

September 15, 2026

Tetratherix Ships First US Polymer, Revenue Begins

August 30, 2026

Application for quotation of securities - TTX

August 23, 2026

Results Presentation 2026

August 19, 2026

Appendix 4E and Annual Report 2026

August 19, 2026

Successful Completion $15M Placement

May 27, 2026

Precision medicine franchise launch and new revenue

March 15, 2026

Tutelix Update

March 9, 2026

Half Yearly Report and Accounts

February 23, 2026

TetraDerm Cohort 1 Results

February 16, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 27, 2026

Executed Henry Schein Agreement

January 18, 2026

TetraDerm Cohort 2

January 12, 2026

Decks in 2026